World's Most Expensive Medicine
Britain's National Health Service (NHS) approved the world's most expensive drug to cure a rare genetic disease. If the disease is rare, its treatment is either complicated or very expensive. This is the most expensive drug in the world made for such a rare disease. The cost of one dose of Zolgensma is 18 crores to treat Spinal Muscular Atrophy (SMA) disease.
National Health Service England said in a statement on Monday that the production by Novartis Jean Therapy had been approved.
Zolgensma single dose priced is 18 crore Indian rupees equivalent to £ 1.79 million pound. The patients who suffering from a disease called genetic spinal muscular atrophy (SMA) require this medicine to cure. Its treatment is considered to be the most expensive in the world. In this disease, the world's most expensive injection is given to patients. SMA is a very rare disease and is characterized by a deficiency of the SMN-1 gene in the body. The chest muscles of the patients suffering from this disease begin to weaken and there is difficulty in breathing.
Scientists claim that one dose of the Zolgensma medicine will cure the disease
Spinal Muscular Atrophy (SMA) disease
Every year many children (sround 80) in England are born with SMA disease. But with this one medicine they can be cured. The only issue is whether everyone can buy such expensive medicine? In this disease, there may be paralysis related to the spinal cord of the child. This condition is caused by the lack of a gene in the body.
SMA is a very rare disease and is characterized by a deficiency of the SMN-1 gene in the body. The chest muscles of the patients suffering from this disease begin to weaken and there is difficulty in breathing.
Treatment of Spinal Muscular Atrophy (SMA) disease.
Complete the deficiency of this gene, Zolgensma drug is highly effective. This single dose corrects the nervous system of the child, the nervous system, by restoring the missing gene back into the body. Paralysis attacks related to the spinal cord do not occur to children.
Manufacturer of Zolgensma
Zolgensma is made by the world-renowned pharmaceutical company Novartis.
On 24 May 2019, the Food and Drug Administration of America approved Zolgensma for the treatment of Spinal Muscular Atrophy (SMA) disease. This is the world's first gene therapy that is designed for children under two years of age.
Trending in India
Parents of #Ayaansh are finding it difficult to raise the required amount for #Zolgensma, Requesting @SonuSood @IlaajIndia @GGovindAgarwal pls help us #SaveAyaaanshGupta. Picture of Ayaansh going viral on Social Media Platform like twitter & FB requesting for save life of Ayaansh.
--END--
0 Comments